Large-scale testing (Phase 3)Study completedNCT00970177
What this trial is testing
Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects 18 or More Years of Age
Who this might be right for
Pandemic Influenza
Novartis Vaccines 812